Results 261 to 270 of about 28,462 (324)

Towards an individualised approach to pain management in inflammatory arthritis. [PDF]

Ther Adv Musculoskelet Dis
Rutter-Locher Z, Denk F, Taams LS, Kirkham BW, Bannister K.   +4 more
europepmc   +1 more source

Mast cell-expressed Mrgprb2/MRGPRX2 mediates gout pain and inflammation via a neuroimmune axis. [PDF]

JCI Insight
Yang L, Liu C, Xiao J, Song Y, Chen H, Li D, Zou C, Hong T, Liu Y, Qi D, Limjunyawong N, Liu W, Qu L.   +12 more
europepmc   +1 more source

Molecular architecture of human dermal sleeping nociceptors. [PDF]

Cell
Körner J, Howard D, Solinski HJ, Mancilla Moreno M, Haag N, Fiebig A, Maxion A, Bhuiyan SA, Toklucu I, Bott RA, Sankaranarayanan I, Tavares-Ferreira D, Shiers S, Inturi NN, Eberhardt E, Ernst L, Bonaguro L, Schulte-Schrepping J, Beyer MD, Stiehl T, Renthal W, Kurth I, Tigerholm J, Serra J, Price TJ, Schmelz M, Namer B, Tripathy S, Lampert A.   +28 more
europepmc   +1 more source

Mitogen- and stress-activated kinase 1 in primary sensory neurons contributes to formalin-induced tonic pain. [PDF]

Pain Rep
Irfan J, Febrianto RM, La Montanara P, Meng MY, Hutson TH, Zimmermann D, Deak-Pocsai K, Aldossary D, Wang J, Di Giovanni S, Kress M, Nagy I.   +11 more
europepmc   +1 more source

Reframing discography through non-binary logic: A dose-response renaissance in spine diagnostics. [PDF]

Interv Pain Med
Stout A.
europepmc   +1 more source

Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery. [PDF]

FASEB J
Khosrowshahi D, Lagae L, Bolander J.
europepmc   +1 more source

The oralis connection: unraveling the complexity of orofacial pain pathways. [PDF]

Pain
Chung MK, Li T, Ren K.
europepmc   +1 more source

Ultrasensitive proteomics uncovers nociceptor diversity and novel pain targets

Chakrabarti S, Makhmut A, Mohammadi A, Luo W, Wang L, Lewin GR, Coscia F.   +6 more
europepmc   +1 more source

Studying human nociceptors: from fundamentals to clinic [PDF]

Brain, 2021
Chronic pain affects one in five of the general population and is the third most important cause of disability-adjusted life-years globally. Unfortunately, treatment remains inadequate due to poor efficacy and tolerability.
Steven J Middleton, Andreas Themistocleous, Patrick Dougherty   +2 more
exaly   +3 more sources

Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors [PDF]

Frontiers in Pharmacology, 2016
Transient receptor potential vanilloid I (TRPV1) sensitization in peripheral nociceptors is a prominent phenomenon that occurs in inflammatory pain conditions.
Antonio Ferrer-Montiel, Sakthikumar Mathivanan, Jean-Pierre Changeux   +2 more
exaly   +3 more sources